August 30, 2023
? April 20, 2023 - STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed). See NOFO PAR-23-144.
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Advancing Translational Sciences (NCATS)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
Office of Research on Women's Health (ORWH)
The purpose of this notice is to inform potential applicants about the updated eligibility criteria for the Resource Limited Institutions for PAR-23-144. This notice applies to receipt dates in September 2024 and 2025 for this funding opportunity.
The current NOFO reads:
In Part 2, Section I, Program Objectives:
The two categories of research active RLIs are defined in Section III of the NOFO:
1) Low Research Active (LRA): An RLI that is an undergraduate or graduate degree granting institution, with at least 35% of undergraduate students supported by Pell grants, and that has had less than six million dollars in NIH research project grant (RPG) support per year in three of the last five years.
2) High Research Active (HRA): An RLI that grants doctoral degrees and has had less than 25 million dollars in NIH RPG support in three of the last five years.
Both LRA and HRA RLIs must have a historical mission to support underrepresented groups in biomedical sciences. Each institution should describe the specific category into which they fit and provide documentation to verify those requirements.
In Part 2, Section III, Eligible Organizations:
RLIs, as defined above, are classified into the following two categories for this opportunity:
1) Low Research Active (LRA): An RLI that is an undergraduate or graduate degree granting institution, with at least 35% of undergraduate students supported by Pell grants, and that has had less than six million dollars in NIH RPG support per year in three of the last five years.
2) High Research Active (HRA): An RLI that grants doctoral degrees and has had less than 25 million dollars in NIH RPG support in three of the last five years.
The Revised NOFO will read:
In Part 2, Section I, Program Objectives:
RLIs, as defined above, are classified into the following two categories for this opportunity:
1) Low Research Active (LRA): An RLI that is an undergraduate or graduate degree granting institution and has had less than six million dollars (total costs) in NIH research project grant (RPG) support per year in three of the last five years. In addition, undergraduate granting institutions must have at least 35% of undergraduate students supported by Pell grants.
2) High Research Active (HRA): An RLI that grants doctoral degrees and has had between six million and 25 million dollars (total costs) in NIH RPG support per year in three of the last five years.
In Part 2, Section III, Eligible Organizations:
RLIs, as defined above, are classified into the following two categories for this opportunity:
1) Low Research Active (LRA): An RLI that is an undergraduate or graduate degree granting institution and has had less than six million dollars (total costs) in NIH research project grant (RPG) support per year in three of the last five years. In addition, undergraduate granting institutions must have at least 35% of undergraduate students supported by Pell grants.
2) High Research Active (HRA): An RLI that grants doctoral degrees and has had between six million and 25 million dollars (total costs) in NIH RPG support per year in three of the last five years.
Scientific/Research Contact(s)
Rina Das, PhD.
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-496-3996
Email: dasr2@mail.nih.gov
Behrous Davani, PhD.
National Cancer Institute (NCI)
Telephone: 240-276-6170
Email: Behrous.davani@nih.gov
and Human Services (HHS)
